Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

R Hu; WB Isaacs; J Luo; Steve Bova; TA Dunn; S Wei; S Isharwal; RW Veltri; E Humphreys; M Han; AW Partin; RL Vessella

doi:10.1158/0008-5472.CAN-08-2764

Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

R Hu
, WB Isaacs
, J Luo
, Steve Bova
, TA Dunn
, S Wei
, S Isharwal
, RW Veltri
, E Humphreys
, M Han
, AW Partin
, RL Vessella

Research output: Contribution to journal › Article › Scientific › peer-review

928 Citations (Scopus)

Original language	English
Pages (from-to)	16-22
Journal	Cancer Research
Volume	69
Issue number	1
DOIs	https://doi.org/10.1158/0008-5472.CAN-08-2764
Publication status	Published - 2009
Externally published	Yes
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472.CAN-08-2764

Cite this

@article{6025175764d242c1a9e09fa4feb7f463,

title = "Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer",

author = "R Hu and WB Isaacs and J Luo and Steve Bova and TA Dunn and S Wei and S Isharwal and RW Veltri and E Humphreys and M Han and AW Partin and RL Vessella",

year = "2009",

doi = "10.1158/0008-5472.CAN-08-2764",

language = "English",

volume = "69",

pages = "16--22",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research",

number = "1",

}

TY - JOUR

T1 - Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

AU - Hu, R

AU - Isaacs, WB

AU - Luo, J

AU - Bova, Steve

AU - Dunn, TA

AU - Wei, S

AU - Isharwal, S

AU - Veltri, RW

AU - Humphreys, E

AU - Han, M

AU - Partin, AW

AU - Vessella, RL

PY - 2009

Y1 - 2009

U2 - 10.1158/0008-5472.CAN-08-2764

DO - 10.1158/0008-5472.CAN-08-2764

M3 - Article

SN - 0008-5472

VL - 69

SP - 16

EP - 22

JO - Cancer Research

JF - Cancer Research

IS - 1

ER -